Cargando…
Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction
[Image: see text] With the demands of the high-throughput assay of biomarkers of ultralow concentrations in clinics, a 36-channel instrument utilizing immunomagnetic reduction (IMR) has been developed. The instrument involves the use of a high-T(c) superconducting-quantum-interference-device (SQUID)...
Autores principales: | Chen, Hsin-Hsien, Hsu, Ming-Hung, Lee, Kun-Hung, Yang, Shieh-Yueh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885996/ https://www.ncbi.nlm.nih.gov/pubmed/36785659 http://dx.doi.org/10.1021/acsmeasuresciau.2c00030 |
Ejemplares similares
-
Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
por: Liu, Huei-Chun, et al.
Publicado: (2020) -
Use of immunomagnetic reduction for C-reactive protein assay in clinical samples
por: Chang, Chien-Hsi, et al.
Publicado: (2012) -
Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021) -
A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay
por: Liu, Bing-Hsien, et al.
Publicado: (2015) -
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)